This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-06-22 and is reviewed periodically as new material appears.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
=== The nucleic acid template hypotheses === Alexander Dounce, of the University of Rochester Medical Center in New York, came close to the correct interpretation of protein synthesis from RNA. In 1952, he proposed the first notion, naming it the "nucleic acid template hypotheses," that proteins were made from RNA, rather than from DNA. However, since the exact chemical structure of DNA or RNA was not known at the time, he suggested erroneously that proteins and RNA have complimentary sequences, as he described in Enzymologia: "the specific arrangement of amino acid residues in a given peptide chain is derived from the specific arrangement of nucleotide residues in a corresponding specific nucleic acid molecule." It was met with criticism in Nature the next year, to which Dounce defended his hypothesis:In the hypothesis proposed by me, ribonucleic acid was deliberately chosen as the template, since it seems probable from a number of considerations and experimental investigations that protein syn- thesis may occur in cytoplasm as well as in nuclei. There can be no objection at the present time to assuming that the genes are templates, but it is not necessary to assume that the genes act directly as templates for protein synthesis.
After World War II the foundation sent a team to West Germany to investigate how it could become involved in reconstructing the country. They focused on restoring democracy, especially regarding education and scientific research, with the long-term goal of reintegrating Germany into the Western world. The foundation also supported the early initiatives of Henry Kissinger, such as his directorship of Harvard's International Seminars (funded as well by the Central Intelligence Agency) and the early foreign policy magazine Confluence, both established by him while he was still a graduate student. In 2021, Rajiv J. Shah, president of the Rockefeller Foundation, released a statement condemning eugenics and supporting the anti-eugenics movement. He stated that
messenger RNA (mRNA) Any of a class of single-stranded RNA molecules which function as molecular messengers, carrying sequence information encoded in the DNA genome to the ribosomes where protein synthesis occurs. The primary products of transcription, mRNAs are synthesized by RNA polymerase, which builds a chain of ribonucleotides that complement the deoxyribonucleotides of a DNA template; in this way, the DNA sequence of a protein-coding gene is effectively preserved in the raw transcript, which is subsequently processed into a mature mRNA by a series of post-transcriptional modifications.
Sources: en.wikipedia.org
== Effects on animals == The biological activity in animals of PMTX was first tested on lobsters by administering it to the neuromuscular synapse in the legs. 10mM of α-PMXT and β-PMXT each was administered, and both toxins enhanced the excitatory postsynaptic potentials (EPSPs). Enhancement of the EPSPs generates oscillatory spike responses and results in longer and larger depolarisations of the muscle membrane which will cause muscle contraction. The β-PMXT is proven to be 5 times more potent than the α-PMXT. The effect of β-PMXT on rat hippocampal CA1 interneurons is proven to be sodium channel modulation, this modulation is due to the toxin slowing the inactivation process of the sodium channels. It is also seen that the effect of the PMTX differs between different cell types, this can be explained by the different distribution of voltage-gated sodium channels in the cell types. In 2016 Konno et.al. experimented with the effect of pompilidotoxins on one insect and seven mammalian voltage-gated sodium channels. From the mammalian sodium channels the Nav1.6 channel gave the most potent effect which indicates that the toxin is selective for this channel. The channel of the insect that was tested for the toxin gave an even greater effect, which is quite logical since the spider wasps target arthropods. The toxin has not yet been tested on arachnids, though it is known that pompilidotoxins are used by spider wasps to paralyse arachnids.
=== Kyrgyzstan === Kyrgyzstan has a similar HIV/AIDS problem as Ukraine and to try and combat this, started a trial methadone program within prisons. The first program started in a solo prison is 2002 and expanded to multiple in 2008. It is estimated that half of incarcerated individuals in Kyrgyzstan inject drugs and the use of unsterilized needles and transfer of HIV is higher in the prison setting. While the offering of methadone in prisons would help curb the spread of HIV/AIDS, the internal prison governance of inmates and their reliance on the drug trade is a hard barrier. Heroin being used as currency as well as methadone users being assigned to separate living quarters than non-users creates a social separation between users and non-users. These outcasting factors can make methadone treatment not worth it for some inmates. The number of eligible prisoners using methadone through a methadone program is estimated at only 7%.
=== Lymphangioleiomyomatosis === In May 2015, the FDA approved sirolimus to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This made sirolimus the first drug approved to treat this disease. LAM involves lung tissue infiltration with smooth muscle-like cells with mutations of the tuberous sclerosis complex gene (TSC2). Loss of TSC2 gene function activates the mTOR signaling pathway, resulting in the release of lymphangiogenic growth factors. Sirolimus blocks this pathway. The safety and efficacy of sirolimus treatment of LAM were investigated in clinical trials that compared sirolimus treatment with a placebo group in 89 patients for 12 months. The patients were observed for 12 months after the treatment had ended. The most commonly reported side effects of sirolimus treatment of LAM were mouth and lip ulcers, diarrhea, abdominal pain, nausea, sore throat, acne, chest pain, leg swelling, upper respiratory tract infection, headache, dizziness, muscle pain and elevated cholesterol. Serious side effects including hypersensitivity and swelling (edema) have been observed in renal transplant patients. While sirolimus was considered for treatment of LAM, it received orphan drug designation status because LAM is a rare condition. The safety of LAM treatment by sirolimus in people younger than 18 years old has not been tested.
Sources: en.wikipedia.org
positional cloning Also map-based cloning. A strategy for identifying and cloning a candidate gene based on knowledge of its locus or position alone and with little or no information about its products or function, in contrast to functional cloning. This method usually begins by comparing the genomes of individuals expressing a phenotype of unknown provenance (often a hereditary disease) and identifying genetic markers shared between them. Regions defined by markers flanking one or more genes of interest are cloned, and the genes located between the markers can then be identified by any of a variety of means, e.g. by sequencing the region and looking for open reading frames, by comparing the sequence and expression patterns of the region in mutant and wild-type individuals, or by testing the ability of the putative gene to rescue a mutant phenotype.
requirement for the safety factor). In a tokamak, instabilities also arise from resistive MHD. For instance, tearing modes are instabilities that arise within the framework of non-ideal MHD. This is an active field of research because these instabilities are the starting point for disruptions.
=== Peptides and proteins === In addition to the amino acids, peptides and proteins bind metal cofactors through their side chains. For the most part, the α-amino and carboxylate groups are unavailable for binding as they are otherwise engaged in the peptide bond. The situation is more complicated for the N-terminal and C-terminal residues where the carboxylate groups and α-amino are unavailable, respectively. Ignoring the N-and C-terminal sites, side chains of the individual residues function as ligands, e.g., histidine (imidazole), cysteine (thiolate), and methionine (thioether).
While the character is usually physically invincible, he demonstrates emotional and psychological vulnerability, exemplifying values and aspirations of resilience for his audience. Flores notes that Wolverine's fanbase consists primarily of men and the character generally exemplifies a masculine perspective on recovery from trauma; despite this, she found him therapeutic in her own recovery from rape. Nnedi Okorafor, a Nigerian American science-fiction author, stated that Wolverine was a therapeutic role model for her during her experience of paralysis following surgical treatment of scoliosis. J. Andrew Deman praises "The Wounded Wolf" story illustrated by Windsor-Smith that appeared in Uncanny X-Men, comparing it to the Iliad. Comic book critics have particularly commended Windsor-Smith's Weapon X story, which describes Wolverine's mistreatment at the hands of the Weapon X program and his experience of trauma. Hagai Palevsky describes it as "quite possibly the best comic Marvel ever published." Rolling Stone journalist Sean T. Collins calls it "Arguably the most important and the most visually impressive Wolverine storyline of all time." In contrast, Paul Young criticizes the trends of the mid-1990s in which Wolverine and other anti-heroes became ubiquitous (he describes this as "Wolverine-mania") and often marketed with gimmick covers. Among later stories, critic Jim Davis considers "Enemy of the State" and "Old Man Logan", both by Millar, to be particularly notable.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.